/Companies

Sepracor

3 known investors

Find your way into Sepracor

Sign up to see every warm intro you have to Sepracor

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Sepracor team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Specialty pharmaceutical company focused on purification of isomers and metabolites, markets Lunesta and Xopenex; acquired by Dainippon Sumitomo Pharma in 2009.

Investors · 3

Founder mafia

2 people who came through Sepracor went on to found or lead other companies.

Frequently asked questions

What does Sepracor do?
Specialty pharmaceutical company focused on purification of isomers and metabolites, markets Lunesta and Xopenex; acquired by Dainippon Sumitomo Pharma in 2009.
Who are Sepracor's investors?
Sepracor's investors include Johnston Associates Inc., New Enterprise Associates (NEA), Venrock.